Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Kythera Biopharmaceuticals"
Count: 23
Selected: 0
| NCT ID | Title |
|---|
| NCT02163902 | Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 | ||
| NCT02159729 | Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 | ||
| NCT02123134 | Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age | ||
| NCT02035267 | Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat | ||
| NCT02438813 | Condition of Submental Fullness and Treatment Outcomes Registry | ||
| NCT01462786 | To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101 | ||
| NCT01426373 | Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area | ||
| NCT00608842 | Phase 2 Study for the Treatment of Superficial Lipomas | ||
| NCT00422188 | Deoxycholic Acid Injection for the Treatment of Superficial Lipomas | ||
| NCT02007434 | Patient Experience Study of Deoxycholic Acid Injection | ||
| NCT01305577 | Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat | ||
| NCT00618722 | Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat | ||
| NCT00618618 | Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat | ||
| NCT01546142 | Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | ||
| NCT01542034 | Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | ||
| NCT01032889 | Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study | ||
| NCT01294644 | Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat | ||
| NCT00618709 | Dose-Escalation Safety and Pharmacokinetic Study of ATX-101 | ||
| NCT01706679 | Evaluation of the Effect of ATX-101 on QT/QTc Intervals | ||
| NCT01632917 | Open-Label Pharmacokinetic Study of Final Formulations of ATX-101 | ||
| NCT01320761 | A Study to Assess Injection Comfort of Two Formulations of ATX-101 | ||
| NCT01319916 | Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue | ||
| NCT00835952 | ATX-101 Abdominoplasty |
